Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.7750
+0.0850 (5.03%)
NASDAQ · Last Trade: Feb 18th, 3:04 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors